7276
P. Shanmugavelan et al. / Bioorg. Med. Chem. Lett. 21 (2011) 7273–7276
8. The Global Alliance for TB Drug Development, The need for new TB drugs, 2006.
Table 3
Experimentally determined MIC values of 1,2,3-triazoles
9. Junior, I. N.; Lourencßo, M. C. S.; Henriques, M. G. M. O.; Ferreira, B.;
Vasconcelos, T. R. A.; Peralta, M. A.; Oliveira, P. S. M.; Wardell, S. M. S. V.; de
Souza, M. V. N. Lett. Drug Des. Disc. 2005, 2, 451.
10. Maccari, R.; Ottana‘, R.; Vigorita, M. G. Bioorg. Med. Chem. Lett. 2005, 15, 2509.
11. Biava, M.; Fioravanti, R.; Porretta, G. C.; Deidda, D.; Maullu, C.; Pompei, R.
Bioorg. Med. Chem. Lett. 1999, 9, 2983.
Triazoles
MIC (lg/mL)
2a
2b
2c
2d
2e
2i
2j
3a
3b
3c
3d
3e
3i
3j
12.5
3.13
6.25
1.56a
3.13
>25
12. Deidda, D.; Lampis, G.; Fioravanti, R.; Biava, M.; Porretta, G. C.; Zanetti, S.;
Pompei, R. Antimicrob. Agents Chemother. 1998, 42, 3035.
13. Zhang, Z. Y.; Liu, Y.; Yang, S. Pharm. Sinica 1991, 26, 809.
14. Genin, M. J.; Allwine, D. A.; Anderson, D. J.; Barbachyn, M. R.; Emmert, D. E.;
Garmon, S. A.; Graber, D. R.; Grega, K. C.; Hester, J. B.; Hutchinson, D. K.; Morris,
J.; Reischer, R. J.; Ford, C. W.; Zurenco, G. E.; Hamel, J. C.; Schaadt, R. D.;
Stapertand, D.; Yagi, B. H. J. Med. Chem. 2000, 43, 953.
15. Japeli, B.; Reccnic, S.; Cebasek, P.; Stanovnik, B.; Svete, J. J. Heterocycl. Chem.
2005, 42, 167.
16. Abdou, N. A.; Soliman, S. N.; Abou Sier, A. H. Bull. Fac. Pharm. 1990, 28, 29.
17. Srivastave, A. J.; Swarup, S.; Saxena, V. K.; Chowdhury, B. L. J. Indian Chem. Soc.
1991, 68, 103.
18. Kooper, J.; Steel, K.; Richardson, K. Chem. Abstr. 1990, 112, 76957u.
19. Kohn, E. C.; Liotta, L. A. Chem. Abstr. 1991, 115, 248099w.
20. Alvarez, R.; Velazquez, S.; San-felix, A.; Aquaro, S.; Declercq, E.; Perno, C. F.;
Kaarlson, A.; Balzarini, J.; Camarasa, M. J. J. Med. Chem. 1994, 37, 4185.
21. De Clercq, E. Med. Res. Rev. 2002, 22, 531.
>25
25
12.5
12.5
3.13
6.25
>25
>25
0.75
3.25
Isoniazid
Ethambutal
a
High potent antitubercular compound.
22. Saito, Y.; Escuret, V.; Duantel, D.; Zoulim, F.; Shcinazi, R. F.; Agrofoglio, L. A.
Bioorg. Med. Chem. 2003, 11, 3633.
23. Himanshu; Tyagi, R.; Olsen, C. E.; Errington, W.; Parmer, V. S.; Prasad, A. K.
Bioorg. Med. Chem. 2002, 10, 963.
Acknowledgments
The author wish to acknowledge IRHPA, DST for providing
300 MHz NMR instrument for recording the NMR spectra, UGC
for giving financial support and Medicinal Chemistry and
Antimycobacterial Research Laboratory, Pharmacy Group, Birla
Institute of Technology and Science, Pilani for biological evaluation
for the compounds synthesised.
24. Velazquez, S.; Alvarez, R.; Perez, C.; Gago, F.; De, C.; Balzarini, J.; Camarasa, M. J.
Antiviral Chem. Chemother. 1988, 9, 481.
25. Garanti, L.; Molteni, G. Tetrahedron Lett. 2003, 44, 1133.
26. Bourne, Y.; Kolb, H. C.; Radic, Z.; Sharpless, K. B.; Taylor, P.; Marchot, P. Proc.
Natl. Acad. Sci. 2004, 101, 1449.
27. (a) Dabak, K.; Sezer, O.; Akar, A.; Anac, O. Eur. J. Med. Chem. 2003, 38, 215; (b)
Costa, M. S.; Boechat, N.; Rangel, E. A.; Silva, F. C.; Souza, A. M. T.; Rodrigues, C.
R.; Castro, H. C.; Junior, I. N.; Lourenc, M. S.; Wardella, M. S. V.; Ferreirab, V. F.
Bioorg. Med. Chem. 2006, 14, 8644; (c) Singh, B. K.; Yadav, A. K.; Brijesh, Kumar.;
Gaikwad, A.; Sinha, A. K.; Chaturvedi, V.; Pati Tripathi, R. Carbohydr. Res. 2008,
343, 1153; (d) Tripathi, R. P.; Yadav, A. K.; Ajay, A.; Bisht, S. S.; Chaturvedi, V.;
Sinha, S. K. Eur. J. Med. Chem. 2010, 4, 142; (e) Thomas, K. D.; Adhikari, A. V.;
Chowdhury, I. M.; Sumesh, E.; Pal, N. K. Eur. J. Med. Chem. 2011, 46, 2503.
28. Krivopalov, V. P.; Shkurko, O. P. Russ. Chem. Rev. 2005, 74, 339.
29. Huisgen, R. In 1,3-Dipolar Cycloaddition Chemistry; Padwa, A., Ed.; Wiley: New
York, 1984; pp 1–176.
Supplementary data
Supplementary data associated with this article can be found, in
References and notes
30. Abu-Orabi, S. T.; Atfah, M. A.; Jibril, I.; Mari’I, F. M.; Ali, A. A. J. Heterocycl. Chem.
1989, 26, 1461.
31. Savin, K. A.; Robertson, Michael; Gernert, Doug; Green, Steven; Hembre, E. J.;
Bishop, Jessie Mol. Divers. 2003, 7, 171.
32. Chang, Chao-Wan; Lee, Gene-Hsiang Organometallics 2003, 22, 3107.
33. Kacprzak, K. Synlett 2005, 6, 943.
1. Tewari, N.; Tiwari, V. K.; Tipathi, R. P.; Chaturvedi, V.; Srivastava, A.; Srivastava,
R.; Shukla, P. K.; Chaturvedi, A. K.; Gaikwad, A.; Sinha, S.; Srivastava, B. S. Bioorg.
Med. Chem. Lett. 2004, 14, 329.
2. World Health Organization, WHO/HTM/TB/2006.
34. International Electronic Conferences on Synthetic Organic Chemistry, 5th, 6th,
Sept. 2001, 2002, 1–30 and 7th, 8th, Nov. 2003, 1–30 and 2004, 914.
35. Zalupsky, P.; Ricka, Z.; Fisera Chem. Pap. 1985, 39, 795.
36. National Committee for Clinical Laboratory Standards, Antimycobacterial
susceptibility testing for Mycobacterium tuberculosis, Proposed Standard
M24-T, National Committee for Clinical Laboratory Standards, Villanova, PA,
1995.
3. Tripathi, R. P.; Tewari, N.; Dwivedi, N.; Tiwari, V. K. Med. Res. Rev. 2005, 25, 93.
4. Guardiola-Diaz, H.; Foster, L. A.; Mushrush, D.; Vaz, A. D. N. Biochem. Pharm.
2001, 61, 1463.
5. Lourencßo, M. C. S.; Grinsztejn, B.; Fandinho-Montes, F. C. O.; da Silva, M. G.;
Saad, M. H. F.; Fonseca, L. S. Trop. Med. Int. Health 2000, 5, 488.
6. Long, R. Can. Med. Assoc. J. 2000, 163, 425.
7. Zhang, Y.; Amzel, L. M. Curr. Drug Targets 2002, 3, 131.